Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 74 Pancreatic Neoplasms 54 Carcinoma, Non-Small-Cell Lung 29 Triple Negative Breast Neoplasms 27 Neoplasm Metastasis 16 Squamous Cell Carcinoma of Head and Neck 15 Ovarian Neoplasms 12 Neoplasms 12 Lung Neoplasms 11 Esophageal Squamous Cell Carcinoma 11 Stomach Neoplasms 10 Esophageal Neoplasms 10 Head and Neck Neoplasms 9 Uterine Cervical Neoplasms 7 Melanoma 7 Cholangiocarcinoma 7 Small Cell Lung Carcinoma 6 Recurrence 6 Sarcoma 5 Pancreatic Adenocarcinoma 5 Inflammatory Breast Neoplasms 5 Fallopian Tube Neoplasms 5 Urinary Bladder Neoplasms 4 Colorectal Neoplasms 4 Advanced Pancreatic Cancer 4 Carcinoma, Transitional Cell 3 Carcinoma, Ovarian Epithelial 3 Breast Neoplasms, Male 3 Adenocarcinoma 3 Uveal Melanoma 2

Interventions

liposomal doxorubicin 1 cemiplimab 1 Paclitaxel 1 Doxorubicin 1 Cyclophosphamide 1 Carboplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Invasive Breast Cancer × Albumin-Bound Paclitaxel × Clear all

NCT04243616 2025-09-05

CemiHALT

Medical College of Wisconsin

Phase 2 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡